Akebia Therapeutics Inc. (AKBA)
1.94
0.05 (2.65%)
At close: Jan 15, 2025, 3:59 PM
1.94
0.26%
After-hours Jan 15, 2025, 04:00 PM EST
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov 7, 2024
(Q3) BMC Q3 2024 | 1.86 | 2.00 | 1.87 | 1.84 | 1.95 | 1.79 | 1.94 | 1.99 | 1.95 | 1.92 | 1.79 | 1.69 | ||
IV: 0.69 RSI: 68 AKBA % | 0.54% | 7.53% | 7.53% | -1.60%
| 4.28%
| -4.28%
| 3.74%
| 2.58% | -2.01% | -1.54% | -3.76% | 1.81% | ||
Aug 8, 2024
(Q2) BMC Q2 2024 | 1.23 | 1.11 | 1.19 | 1.19 | 1.23 | 1.11 | 1.11 | 1.23 | 1.34 | 1.35 | 1.44 | 1.25 | ||
IV: 1.14 RSI: 45 AKBA % | 3.36% | -9.76% | -9.76% | 0.00%
| 3.36%
| -6.72%
| -6.72%
| 10.81% | 8.94% | 0.75% | 0.00% | -3.10% | ||
May 9, 2024
(Q1) BMC Q1 2024 | 1.40 | 1.40 | 1.33 | 1.25 | 1.33 | 1.19 | 1.21 | 1.29 | 1.23 | 1.18 | 1.15 | 1.37 | ||
IV: 0.83 RSI: 43 AKBA % | -6.04% | 0.00% | 0.00% | -6.02%
| 0.00%
| -10.53%
| -9.02%
| 6.61% | -4.65% | -4.07% | 0.88% | 5.38% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.